Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1634 | Thyroid (non-cancer) | ICEECE2012

Prediction of remission rate in the patients with Graves’ disease after treatment with a minimum maintenance dose of Methimazole

Beniko M. , Ikawa H. , Mori T. , Kudo H. , Matsumoto A. , Sekiguchi M. , Mashio Y.

Introduction: According to the guideline for medical treatment of Graves’ disease by the Japan Thyroid Association in 2011, discontinuation of antithyroid drug is recommended when normal thyroid functions have been maintained for a certain period (≥6 months) after treatment with a minimum maintenance dose (mentioned below). We prospectively studied the remission rates in the patients with Graves’ disease.Methods: The subjects were 108 pat...